- Ondansetron 4mg/2ml solution for injection ampoules
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Ondansetron 4mg/2ml solution for injection ampoules | Start Date 21-01-2009 | End Date |
Previous Name | Previous Name Ondansetron 4mg/2ml solution for infusion ampoules | Start Date 19-01-2009 |
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 2
- UDFS UOM
- ml
- Unit Dose UOM
- ampoule
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intramuscular, Intravenous
- Form
- Solution for injection
- Ontology Form/Route
- solutioninjection.intramuscular, solutioninjection.intravenous, solutioninfusion.intravenous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- A04AA01
BNF | Start Date | End Date |
---|---|---|
Current BNF 04060000 | Start Date 04-04-2022 | End Date |
Previous BNF 04060000 | Start Date 14-02-2005 | End Date 03-04-2022 |
Code | Start Date | End Date |
---|---|---|
36022411000001102 | 29-10-2018 | |
322172006 | 12-03-2003 | 28-10-2018 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Ondansetron hydrochloride dihydrate | Based on Base Substance | Ondansetron | 2 mg | 1 ml |
Name
Ondansetron hydrochloride dihydrate
Basis of strength description
Based on Base Substance
BOSS
Ondansetron
Strength and UOM (Nmr)
2
Strength and UOM (Dmr)
1
Parent Products
-
VTMOndansetron
-
VMP(Current) Ondansetron 4mg/2ml solution for inj...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
5 ampoule | ||
10 ampoule | 2000 | Part VIIIA Category C |